Rok Ješe

462 total citations
21 papers, 283 citations indexed

About

Rok Ješe is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Genetics. According to data from OpenAlex, Rok Ješe has authored 21 papers receiving a total of 283 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 15 papers in Rheumatology and 6 papers in Genetics. Recurrent topics in Rok Ješe's work include Vasculitis and related conditions (16 papers), Otitis Media and Relapsing Polychondritis (7 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers). Rok Ješe is often cited by papers focused on Vasculitis and related conditions (16 papers), Otitis Media and Relapsing Polychondritis (7 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers). Rok Ješe collaborates with scholars based in Slovenia, Austria and Hungary. Rok Ješe's co-authors include Matija Tomšič, Žiga Rotar, Alojzija Hočevar, Marko Hawlina, Jože Pižem, Tadeja Kuret, Katja Lakota, Sonja Praprotnik, Polona Žigon and Gerhard Thallinger and has published in prestigious journals such as Annals of the Rheumatic Diseases, Medicine and Lara D. Veeken.

In The Last Decade

Rok Ješe

20 papers receiving 280 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rok Ješe Slovenia 9 243 182 64 53 39 21 283
Nicolò Pipitone Italy 7 196 0.8× 191 1.0× 48 0.8× 69 1.3× 51 1.3× 10 308
Jos Austen Netherlands 6 148 0.6× 112 0.6× 71 1.1× 81 1.5× 42 1.1× 6 287
Lindsay Lally United States 9 185 0.8× 153 0.8× 90 1.4× 32 0.6× 17 0.4× 19 257
Chiara Marvisi Italy 12 192 0.8× 279 1.5× 72 1.1× 31 0.6× 22 0.6× 41 374
Fabian Arndt Germany 4 207 0.9× 151 0.8× 47 0.7× 39 0.7× 20 0.5× 6 245
C. Agard France 7 185 0.8× 103 0.6× 29 0.5× 84 1.6× 36 0.9× 12 344
Silke Pitann Germany 6 183 0.8× 79 0.4× 50 0.8× 98 1.8× 28 0.7× 13 233
Jan Henrik Schirmer Germany 9 210 0.9× 97 0.5× 53 0.8× 36 0.7× 33 0.8× 22 293
Ana Águeda Portugal 6 149 0.6× 126 0.7× 37 0.6× 40 0.8× 42 1.1× 18 216
Mark McClure United Kingdom 9 187 0.8× 114 0.6× 110 1.7× 70 1.3× 55 1.4× 18 276

Countries citing papers authored by Rok Ješe

Since Specialization
Citations

This map shows the geographic impact of Rok Ješe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rok Ješe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rok Ješe more than expected).

Fields of papers citing papers by Rok Ješe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rok Ješe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rok Ješe. The network helps show where Rok Ješe may publish in the future.

Co-authorship network of co-authors of Rok Ješe

This figure shows the co-authorship network connecting the top 25 collaborators of Rok Ješe. A scholar is included among the top collaborators of Rok Ješe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rok Ješe. Rok Ješe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ješe, Rok, et al.. (2022). COVID-19 among patients with giant cell arteritis: a single-centre observational study from Slovenia. Clinical Rheumatology. 41(8). 2449–2456. 6 indexed citations
2.
Hočevar, Alojzija, Rok Ješe, Matija Tomšič, & Žiga Rotar. (2020). Risk factors for severe cranial ischaemic complications in giant cell arteritis. Lara D. Veeken. 59(10). 2953–2959. 20 indexed citations
3.
Ješe, Rok, Žiga Rotar, Matija Tomšič, & Alojzija Hočevar. (2020). FRI0193 ULTRASONOGRAPHY IN THE DIAGNOSIS OF GIANT CELL ARTERITIS. Annals of the Rheumatic Diseases. 79. 680–680. 1 indexed citations
4.
Ješe, Rok, Žiga Rotar, Matija Tomšič, & Alojzija Hočevar. (2020). The cut-off values for the intima–media complex thickness assessed by colour Doppler sonography in seven cranial and aortic arch arteries. Lara D. Veeken. 60(3). 1346–1352. 39 indexed citations
5.
Hočevar, Alojzija, et al.. (2019). The incidence of spondyloarthritis in Slovenia. Medicine. 98(26). e16177–e16177. 5 indexed citations
6.
Feichtinger, Julia, Katja Lakota, Gerhard Thallinger, et al.. (2018). Utility of serological biomarkers for giant cell arteritis in a large cohort of treatment-naïve patients. Clinical Rheumatology. 38(2). 317–329. 34 indexed citations
7.
Hočevar, Alojzija, Rok Ješe, Žiga Rotar, & Matija Tomšič. (2018). Does leflunomide have a role in giant cell arteritis? An open-label study. Clinical Rheumatology. 38(2). 291–296. 38 indexed citations
8.
Hočevar, Alojzija, Rok Ješe, Žiga Rotar, et al.. (2018). The incidence of giant cell arteritis in Slovenia. Clinical Rheumatology. 38(2). 285–290. 10 indexed citations
9.
Ješe, Rok, et al.. (2018). The incidence rate and the early management of rheumatoid arthritis in Slovenia. Clinical Rheumatology. 38(2). 273–278. 3 indexed citations
10.
Ješe, Rok, Žiga Rotar, Matija Tomšič, & Alojzija Hočevar. (2018). Giant Cell Arteritis and Malignancy—More Than Just a Coincidence?. JCR Journal of Clinical Rheumatology. 24(2). 85–86. 5 indexed citations
11.
Ješe, Rok, et al.. (2018). THU0448 Is there an association between adult iga vasculitis and cancer?. Annals of the Rheumatic Diseases. 77. 436–436. 1 indexed citations
12.
Hočevar, Alojzija, Rok Ješe, Žiga Rotar, & Matija Tomšič. (2018). SAT0518 The role of leflunomide in the treatment of giant cell arteritis. Annals of the Rheumatic Diseases. 77. 1114–1115. 1 indexed citations
13.
Kuret, Tadeja, Katja Lakota, Žiga Rotar, et al.. (2017). A concise review of significantly modified serological biomarkers in giant cell arteritis, as detected by different methods. Autoimmunity Reviews. 17(2). 188–194. 17 indexed citations
14.
Ješe, Rok, Žiga Rotar, Matija Tomšič, & Alojzija Hočevar. (2017). The role of colour doppler ultrasonography of facial and occipital arteries in patients with giant cell arteritis: A prospective study. European Journal of Radiology. 95. 9–12. 37 indexed citations
15.
Lakota, Katja, Julia Feichtinger, Tadeja Kuret, et al.. (2017). THU0054 Utility of serological parameters in giant cell arteritis for predicting disease complications. Annals of the Rheumatic Diseases. 76. 219–219. 1 indexed citations
16.
Hočevar, Alojzija, Rok Ješe, Žiga Rotar, et al.. (2017). AB0552 Antiphospholipid antibodies in giant cell arteritis. Annals of the Rheumatic Diseases. 76. 1243–1244. 2 indexed citations
17.
Ješe, Rok, Aleš Ambrožič, Nataša Gašperšič, et al.. (2016). AB0238 The Performance of A Single Centre Interventional Clinic in Early Rheumatoid Arthritis. Annals of the Rheumatic Diseases. 75. 979–979. 1 indexed citations
18.
Hočevar, Alojzija, Žiga Rotar, Rok Ješe, et al.. (2016). Do Early Diagnosis and Glucocorticoid Treatment Decrease the Risk of Permanent Visual Loss and Early Relapses in Giant Cell Arteritis. Medicine. 95(14). e3210–e3210. 49 indexed citations
19.
Hočevar, Alojzija, Žiga Rotar, Rok Ješe, et al.. (2015). THU0268 Visual Complications in Giant Cell Arteritis – Beyond Inflammation. Annals of the Rheumatic Diseases. 74. 293–294. 1 indexed citations
20.
Ješe, Rok, Žiga Rotar, Sonja Praprotnik, Alojzija Hočevar, & Matija Tomšič. (2014). AB0581 The Estimated Annual Incidence Rate of Polyarteritis Nodosa in Slovenia. Annals of the Rheumatic Diseases. 73. 998–998.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicolò Pipitone Breakdown of academic impact, for papers by Jos Austen Breakdown of academic impact, for papers by Lindsay Lally Breakdown of academic impact, for papers by Chiara Marvisi Breakdown of academic impact, for papers by Fabian Arndt Breakdown of academic impact, for papers by C. Agard Breakdown of academic impact, for papers by Silke Pitann Breakdown of academic impact, for papers by Jan Henrik Schirmer Breakdown of academic impact, for papers by Ana Águeda Breakdown of academic impact, for papers by Mark McClure
Rankless by CCL
2026